SUN PHARMA’s Post

Uncover new pathways trough pharmaceutical partnership models with Nubinno Connect - https://lnkd.in/dyVmZfDW #pharmainnovation #strategicalliances #collaborations #strategicalliance #licenseagreement #codevelopment #strategicequityinvestments #acquisitions

A new paper produced by a group of Swiss and German researchers estimates that the R&D cost to produce one new drug is in the order of USD 6bn. This value is significantly higher than previous estimates that were in the order of USD 2.5-3bn. In a fair share of pharma companies R&D productivity (RoI) is negative and can only be compensated for by the acquisition of outside assets, through mergers and acquisitions. #drugdevelopment #bigpharma

We expect a wave of small to mid-sized acquisitions by the large pharmaceutical companies in our coverage universe in the next several years. In our latest blog post, we discuss the main drivers of upcoming mergers and acquisitions and what this means for the pharmaceutical industry. https://bit.ly/4bETuXU

Looking towards the future, the pharmaceutical landscape is set for further transformation. Find out what the forecast holds for mergers and acquisitions in 2024, and how this could shape the industry's future growth and development. #PharmaForecast #FutureGrowth

In the dynamic landscape of the pharmaceutical industry, mergers and acquisitions serve as powerful strategic moves, promising growth, diversification, and enhanced market reach. However, with these opportunities come intricate challenges, especially when it involves the melding of critical functions like pharmacovigilance from multiple entities into a singular, coherent system. The complexity of such an endeavor can be likened to merging several distinct rivers into one powerful and unified stream, ensuring each tributary flows smoothly without causing turbulence. This case study delves into AWINSA’s monumental task of integrating diverse pharmacovigilance systems for one of our Pharmaceutical clients, highlighting the challenges faced, solutions implemented, and the impressive results achieved. Journey with us as we unravel the meticulous strategies and collaborations that transformed potential chaos into a symphony of seamless operations. View more: https://lnkd.in/dfshAiXw

In the dynamic landscape of the pharmaceutical industry, mergers and acquisitions serve as powerful strategic moves, promising growth, diversification, and enhanced market reach. However, with these opportunities come intricate challenges, especially when it involves the melding of critical functions like pharmacovigilance from multiple entities into a singular, coherent system. The complexity of such an endeavor can be likened to merging several distinct rivers into one powerful and unified stream, ensuring each tributary flows smoothly without causing turbulence. This case study delves into AWINSA’s monumental task of integrating diverse pharmacovigilance systems for one of our Pharmaceutical clients, highlighting the challenges faced, solutions implemented, and the impressive results achieved. Journey with us as we unravel the meticulous strategies and collaborations that transformed potential chaos into a symphony of seamless operations. View more: https://lnkd.in/dfshAiXw

💥SUN PHARMA Limited and Taro Pharmaceuticals Industries Ltd. announced that Taro's shareholders approved the merger with Sun Pharma on May 22, 2024. 💥This merger will highlight the potential to better serve global patients and customers. 💥Uday Baldota, Taro's CEO, noted the benefits of Taro's long relationship with Sun Pharma and how the merger will enhance their competitive edge. 💥The merger is expected to be completed in about 35 days, pending certain conditions. After the merger, Taro will become a privately held company owned by Sun Pharma and will be de-listed from the NYSE. #sunpharma #TaroPharmaceuticals #merger #betterhealth #health #globalization #nyse

The European Commission recently published a report summarising the enforcement of EU antitrust and merger rules in pharma between 2018 and 2022. Read the key takeaways here: #antitrust #merger #EU #pharma

In the dynamic landscape of the pharmaceutical industry, mergers and acquisitions serve as powerful strategic moves, promising growth, diversification, and enhanced market reach. However, with these opportunities come intricate challenges, especially when it involves the melding of critical functions like pharmacovigilance from multiple entities into a singular, coherent system. The complexity of such an endeavor can be likened to merging several distinct rivers into one powerful and unified stream, ensuring each tributary flows smoothly without causing turbulence. This case study delves into AWINSA’s monumental task of integrating diverse pharmacovigilance systems for one of our Pharmaceutical clients, highlighting the challenges faced, solutions implemented, and the impressive results achieved. Journey with us as we unravel the meticulous strategies and collaborations that transformed potential chaos into a symphony of seamless operations. View more: https://lnkd.in/dfshAiXw

In the dynamic landscape of the pharmaceutical industry, mergers and acquisitions serve as powerful strategic moves, promising growth, diversification, and enhanced market reach. However, with these opportunities come intricate challenges, especially when it involves the melding of critical functions like pharmacovigilance from multiple entities into a singular, coherent system. The complexity of such an endeavor can be likened to merging several distinct rivers into one powerful and unified stream, ensuring each tributary flows smoothly without causing turbulence. This case study delves into AWINSA’s monumental task of integrating diverse pharmacovigilance systems for one of our Pharmaceutical clients, highlighting the challenges faced, solutions implemented, and the impressive results achieved. Journey with us as we unravel the meticulous strategies and collaborations that transformed potential chaos into a symphony of seamless operations. View more: https://lnkd.in/dfshAiXw